Event Type
Disclosure
Mandatory
Variant
8-K
Bankruptcy or Receivership. On March 21, 2025, Kiromic BioPharma, Inc. (the "Company") filed a voluntary petition for relief (the "Bankruptcy Filing") under the
Departure of Directors or Certain Officers ; Election of Directors ; Appointment of Certain Officers ; Compensatory Arrangements of Certain Officers. Pietro Ber